Editor
TSMC Earnings Jumped 77%. Chip Stocks Sold Off Anyway. Sound Familiar?
TSMC earnings came in Thursday with a number that would make most CEOs celebrate. Profit up 77% year over year. Guidance raised.
Shares fell more than 4%.
If this feels like déjà vu, that’s because it is. Samsung did this exact thing two weeks ago. JPMorgan did it Tuesday. ASML did it Wednesday. Now TSMC, the largest chipmaker on the planet, just became the fourth blowout earnings report this month to get sold, not bought.
Four times. Same script. Something’s shifted.
Why TSMC Earnings Couldn’t Stop the Chip Slide
The mechanics this time trace back to a very specific worry: are the hyperscalers about to slow down?
“Nobody’s questioning TSMC’s execution. They’re questioning whether Microsoft, Amazon, and Meta keep spending at this pace into 2027,” said Marcus Thorne, Head of Macro Strategy at a New York boutique advisory firm. “A 77% profit jump is backward-looking. The stock trades on the next four quarters, and right now, there’s real skepticism building about whether AI infrastructure capex holds up if the Fed stays hawkish and borrowing costs stay elevated.”
That skepticism has teeth. Micron, AMD, SanDisk, Intel, Broadcom, all dropped roughly 3% to 5% Thursday. South Korea added fuel by banning leveraged ETF products tied to the sector, choking off some of the speculative demand that’s powered chip names all year. ASML’s own comments about building more efficient, less labor-intensive machines didn’t help either. Efficiency gains sound great in a press release. They sound like reduced future orders to a nervous trader.
Layered on top: retail sales beat expectations. Jobless claims stayed low. Strong economic data, normally good news, now reads as more ammunition for a Fed rate hike, especially with oil elevated on renewed Iran strikes. The 10-year yield barely moved off its recent highs. Rate-sensitive growth stocks, chips very much included, don’t love that combination.
The Skeptic Who Says This Is Overdone
Not everyone’s buying the capex-slowdown fear.
“Show me the actual guidance cut. I’ll wait,” countered Elena Voss, senior equity strategist at a Chicago research shop. “TSMC didn’t lower its outlook. It raised it. Every hyperscaler earnings call this year has confirmed rising, not falling, AI spending plans. What we’re seeing is a market that spent six months pricing in flawless execution, and now flinches every time a headline gives it permission to take profits. That’s positioning, not fundamentals.”
Voss has a point worth weighing. UnitedHealth surged 7% Thursday on its own earnings beat and raised guidance, no punishment at all. The selling is concentrated almost entirely in one sector. That’s not a market-wide flight from risk. It’s chips specifically, getting re-rated after an extraordinary run.
What This Means for Your Portfolio
Four good-earnings-bad-reaction events in one month isn’t noise anymore. It’s a pattern, and patterns are worth respecting even when the underlying fundamentals still look fine.
Here’s the mechanism worth understanding: when a sector’s valuation has run far ahead of its own excellent results, “excellent” stops being enough. The market starts trading the stock on what could go wrong, capex pullbacks, rate hikes, efficiency gains reducing order volume, rather than what’s already gone right. That’s where chips sit right now.
The practical move isn’t abandoning the sector. It’s checking your exposure against your conviction. If you’re holding chip names purely on momentum, this is the kind of week that tests whether you actually believe in the multi-year thesis or just liked the chart. If you do believe it, a string of sell-the-news reactions on genuinely strong earnings is often where patient money adds, not exits.
Watch two things going forward: whether any hyperscaler actually trims capex guidance in the coming weeks, and where the 10-year yield settles once this Fed-hike chatter either firms up or fades. Real guidance cuts would validate the fear. A cooling in rate-hike bets would probably send this exact same money right back into the same beaten-down names.
For now, chips keep delivering the numbers. The market just isn’t rewarding them for it. Worth watching how long that lasts.
